Treatment of mucosal leishmaniasis with a lipid formulation of amphotericin B.

MLA

Amato, Valdir Sabbaga, et al. “Treatment of Mucosal Leishmaniasis with a Lipid Formulation of Amphotericin B.” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 44, no. 2, Jan. 2007, pp. 311–12. EBSCOhost, https://doi.org/10.1086/510494.

APA

Amato, V. S., Tuon, F. F., Campos, A., Bacha, H. A., Nicodemo, A. C., Amato Neto, V., & Shikanai-Yasuda, M. A. (2007). Treatment of mucosal leishmaniasis with a lipid formulation of amphotericin B. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 44(2), 311–312. https://doi.org/10.1086/510494

Chicago

Amato, Valdir Sabbaga, Felipe Francisco Tuon, Aleia Campos, Helio Arthur Bacha, Antonio Carlos Nicodemo, Vicente Amato Neto, and Maria Aparecida Shikanai-Yasuda. 2007. “Treatment of Mucosal Leishmaniasis with a Lipid Formulation of Amphotericin B.” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 44 (2): 311–12. doi:10.1086/510494.